PDRG1

Across TCGA pan-cancer cohorts, PDRG1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of PDRG1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where PDRG1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types PDRG1 is over-expressed in tumor.

HNSC, COAD, and LUAD are the cancer types where PDRG1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in PDRG1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.236	<.001	11	view →
COAD	Female	All	+0.576	<.001	9	view →
LUAD	Male	III,IV	+0.570	<.001	9	view →
LSCC	Male	All	+0.638	<.001	8	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

PDRG1–HNSC

Open the HNSC breakdown →